PET‐CT confirmed complete remission and MRD negativity in mantle cell lymphoma patients treated with R‐hyper‐CVAD results in excellent outcome in the absence of autologous stem cell transplantation: a single‐centre case for a transplant‐free approach

By  

INTERNAL MEDICINE JOURNAL, Vol. 46, Iss. 9, 2016-09 ,pp. : 1113-1114

John Wiley & Sons Inc

Access to resources Recommend Favorite

Successful treatment of AIDS-associated, primary CNS lymphoma with rituximab- and methotrexate-based chemotherapy and autologous stem cell transplantation

By Wolf T.   Kiderlen T.   Atta J.   Stephan C.   Kann G.   Brodt H.-R.   Brandts C.  

Infection, Vol. 42, Iss. 2, 2014-04 ,pp. : 445-447

Springer Publishing Company

Access to resources Recommend Favorite

Computerized image analysis of the Ki‐67 proliferation index in mantle cell lymphoma

By  

HISTOPATHOLOGY, Vol. 67, Iss. 1, 2015-07 ,pp. : 62-69

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase I/II trial of vorinostat with rituximab, cyclophosphamide, etoposide and prednisone as palliative treatment for elderly patients with relapsed or refractory diffuse large B‐cell lymphoma not eligible for autologous stem cell transplantation

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 5, 2015-03 ,pp. : 663-670

John Wiley & Sons Inc

Access to resources Recommend Favorite

Autologous Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission: A Meta-Analysis of Randomized Trials

By  

Acta Haematologica, Vol. 124, Iss. 2, 2010-07 ,pp. : 61-71

Karger

Access to resources Recommend Favorite